Medicines Marketed by Elder Pharmaceuticals Ltd

About Elder Pharmaceuticals Ltd

Elder Pharmaceuticals Ltd is a well-established player in the Indian pharmaceutical industry, operating in the sector since its incorporation in 1983. Based in Mumbai, Maharashtra, the company focuses on the manufacturing and marketing of bulk medicines and related products. While Elder Pharmaceuticals has a strong presence in the Indian market, it has also forged international collaborations and ventures, indicating a global outreach and expansion to countries like Bulgaria.

Elder Pharmaceuticals Ltd offers a diverse range of products, including prescription pharmaceutical brands across various therapeutic segments such as gynaecology, pain management, and cerebro-neuropsychiatry (CNS). The company also manufactures and markets surgical and medical devices, nutraceuticals, and has entered the oral care and personal hygiene segments with products like mouthwash and the Vagisil range of feminine hygiene products in collaboration with Combe.

Elder Pharmaceuticals Ltd Products

Elder Pharmaceuticals Ltd produces a wide array of pharmaceutical products catering to different therapeutic areas. Their portfolio includes anti-hypertensive medicines, osteoarthritis and pain management medications, and products in the CNS segment. The company has also launched several products in the gynaecology and women's health segment, demonstrating their commitment to addressing the specific needs of female consumers.

In addition to pharmaceuticals, Elder Pharmaceuticals is expanding its presence in the nutraceuticals sector, focusing on dietary supplements that provide medical or health benefits. The company has gained recognition for its range of feminine personal hygiene products, launched in collaboration with Combe, and its pain management and osteoarthritis medicatios introduced through strategic alliances with partners like Swiss pharma major TRB Chemedica. Elder Pharmaceuticals' diversified product portfolio, extensive international collaborations, investments in research and development, and strategic expansions set it apart in the market, showcasing its commitment to growth, innovation, and catering to a broad range of consumer needs in the pharmaceutical sector.